Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5185585
Max Phase: Preclinical
Molecular Formula: C20H15NO3
Molecular Weight: 317.34
Associated Items:
ID: ALA5185585
Max Phase: Preclinical
Molecular Formula: C20H15NO3
Molecular Weight: 317.34
Associated Items:
Canonical SMILES: O=C(/C=C/c1ccco1)c1ccc(NC(=O)c2ccccc2)cc1
Standard InChI: InChI=1S/C20H15NO3/c22-19(13-12-18-7-4-14-24-18)15-8-10-17(11-9-15)21-20(23)16-5-2-1-3-6-16/h1-14H,(H,21,23)/b13-12+
Standard InChI Key: RATBDDHMCZSNDB-OUKQBFOZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 317.34 | Molecular Weight (Monoisotopic): 317.1052 | AlogP: 4.43 | #Rotatable Bonds: 5 |
Polar Surface Area: 59.31 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.04 | CX LogD: 4.04 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.56 | Np Likeness Score: -1.08 |
1. Chitre S, Ray AM, Stevens M, Doud EH, Liechty H, Washburn A, Tepper K, Sivinski J, O'Hagan HM, Georgiadis MM, Chapman E, Johnson SM.. (2022) Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol., 75 [PMID:36356534] [10.1016/j.bmc.2022.117072] |
Source(1):